Total Payments
$4,775
2024 Payments
$275.93
Companies
35
Transactions
332
Medicare Patients
9,874
Medicare Billing
$825,879
Payment Breakdown by Category
Food & Beverage$4,767 (99.8%)
Education$7.58 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,767 | 331 | 99.8% |
| Education | $7.58 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $538.36 | 42 | $0 (2024) |
| PFIZER INC. | $478.32 | 41 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $421.59 | 30 | $0 (2021) |
| Amgen Inc. | $413.83 | 28 | $0 (2023) |
| Gilead Sciences, Inc. | $326.47 | 29 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $299.97 | 17 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $299.39 | 21 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $298.95 | 28 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $242.39 | 16 | $0 (2024) |
| Esperion Therapeutics, Inc. | $193.86 | 18 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $275.93 | 12 | Eitan Medical North America, Inc. ($84.59) |
| 2023 | $324.77 | 17 | PFIZER INC. ($104.75) |
| 2022 | $457.31 | 30 | Novartis Pharmaceuticals Corporation ($121.15) |
| 2021 | $543.62 | 43 | Esperion Therapeutics, Inc. ($152.92) |
| 2020 | $590.32 | 31 | Medicure Pharma Inc. ($158.82) |
| 2019 | $827.74 | 61 | SANOFI-AVENTIS U.S. LLC ($150.10) |
| 2018 | $702.91 | 50 | Gilead Sciences, Inc. ($116.19) |
| 2017 | $1,052 | 88 | Gilead Sciences Inc ($164.10) |
All Payment Transactions
332 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: Cardiovascular | ||||||
| 09/20/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $27.50 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 07/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/22/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| Category: Cardiovascular | ||||||
| 05/02/2024 | Eitan Medical North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $84.59 | General |
| 04/26/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Iron Deficiency Anemia | ||||||
| 04/09/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $20.02 | General |
| Category: Cardiovascular | ||||||
| 03/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: DIABETES | ||||||
| 02/02/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: Cardiovascular | ||||||
| 01/16/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 12/15/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/29/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/21/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/02/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.95 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/23/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardiology | ||||||
| 10/20/2023 | E.R. Squibb & Sons, L.L.C. | COUMADIN (Drug) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: Cardiovascular | ||||||
| 09/25/2023 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/28/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Cardiology | ||||||
| 06/21/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $13.93 | General |
| Category: Cardiovascular | ||||||
| 06/05/2023 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $52.02 | General |
| Category: WATCHMAN_IC | ||||||
| 05/24/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: Cardiovascular | ||||||
| 05/23/2023 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,424 | 3,623 | $859,607 | $202,640 |
| 2022 | 19 | 2,202 | 3,214 | $710,830 | $183,564 |
| 2021 | 19 | 2,504 | 3,669 | $776,483 | $222,649 |
| 2020 | 22 | 2,744 | 3,945 | $803,720 | $217,027 |
Total Patients
9,874
Total Services
14,451
Medicare Billing
$825,879
Procedure Codes
90
All Medicare Procedures & Services
90 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 568 | 1,170 | $322,920 | $99,277 | 30.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 299 | 311 | $192,799 | $40,695 | 21.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 112 | 240 | $44,880 | $13,864 | 30.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 195 | 197 | $105,789 | $9,861 | 9.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 54 | 54 | $39,852 | $8,133 | 20.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 65 | $23,010 | $6,025 | 26.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $17,640 | $4,554 | 25.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 502 | 606 | $25,712 | $3,480 | 13.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 227 | 334 | $26,391 | $3,047 | 11.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 28 | $7,532 | $2,401 | 31.9% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 23 | 27 | $15,363 | $2,042 | 13.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $5,775 | $1,373 | 23.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 106 | 148 | $3,848 | $1,236 | 32.1% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 13 | 52 | $3,025 | $1,196 | 39.5% |
| 93224 | Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | Office | 2023 | 21 | 21 | $5,229 | $994.60 | 19.0% |
| Q9950 | Injection, sulfur hexafluoride lipid microspheres, per ml | Office | 2023 | 13 | 65 | $3,493 | $949.64 | 27.2% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 11 | 22 | $3,021 | $736.06 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 12 | $2,916 | $729.41 | 25.0% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 21 | 21 | $2,583 | $569.94 | 22.1% |
| 85610 | Blood test, clotting time | Office | 2023 | 55 | 133 | $3,591 | $558.60 | 15.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 19 | 19 | $1,406 | $353.21 | 25.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 14 | 15 | $1,080 | $210.13 | 19.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 17 | 17 | $816.00 | $177.99 | 21.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 12 | 13 | $936.00 | $175.01 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 566 | 1,113 | $292,719 | $92,757 | 31.7% |
About Dr. Stanislaw Sojka, MD
Dr. Stanislaw Sojka, MD is a Cardiovascular Disease healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013978196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stanislaw Sojka, MD has received a total of $4,775 in payments from pharmaceutical and medical device companies, with $275.93 received in 2024. These payments were reported across 332 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,767).
As a Medicare-enrolled provider, Sojka has provided services to 9,874 Medicare beneficiaries, totaling 14,451 services with total Medicare billing of $825,879. Data is available for 4 years (2020–2023), covering 90 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Omaha, NE
- Active Since 03/29/2006
- Last Updated 06/12/2015
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1013978196
Products in Payments
- ENTRESTO (Drug) $506.39
- BRILINTA (Drug) $329.76
- XARELTO (Drug) $299.39
- LifeVest (Device) $298.95
- ELIQUIS (Drug) $290.64
- MULTAQ (Drug) $274.64
- Corlanor (Drug) $219.34
- Repatha (Biological) $194.49
- NEXLETOL (Drug) $193.86
- CAMZYOS (Drug) $162.89
- HMG-CoA reductase inhibitor. (Drug) $158.82
- PRALUENT (Drug) $146.95
- VYNDAQEL (Drug) $145.80
- CHANTIX (Drug) $106.99
- PRALUENT ALIROCUMAB INJECTION (Biological) $97.40
- PRADAXA (Drug) $71.50
- Vascepa (Drug) $67.71
- VERQUVO (Drug) $57.64
- BYSTOLIC (Drug) $53.08
- WATCHMAN Access System (Device) $52.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Omaha
Ronald Zolty, Md, MD
Cardiovascular Disease — Payments: $1.1M
Cardiovascular Disease $1.1M
Jeffrey Mahoney, Md, MD
Cardiovascular Disease — Payments: $347,757
Cardiovascular Disease $347,757
Jeffrey Carstens, Md, MD
Cardiovascular Disease — Payments: $174,916
Cardiovascular Disease $174,916
Dr. Joseph Thibodeau, M.d, M.D
Cardiovascular Disease — Payments: $174,146
Cardiovascular Disease $174,146
John Henry, Md, MD
Cardiovascular Disease — Payments: $124,773
Cardiovascular Disease $124,773
Dr. Hussam Abuissa, M.d, M.D
Cardiovascular Disease — Payments: $120,084
Cardiovascular Disease $120,084